BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32892309)

  • 1. Will
    Giovanella L; Bacigalupo L; Treglia G; Piccardo A
    Endocrine; 2021 Feb; 71(2):285-297. PubMed ID: 32892309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Cervical Ultrasound,
    Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
    J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods.
    Treglia G; Trimboli P; Huellner M; Giovanella L
    Minerva Endocrinol; 2018 Jun; 43(2):133-143. PubMed ID: 28650133
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cuderman A; Senica K; Rep S; Hocevar M; Kocjan T; Sever MJ; Zaletel K; Lezaic L
    J Nucl Med; 2020 Apr; 61(4):577-583. PubMed ID: 31562221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
    Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
    Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
    Amadou C; Bera G; Ezziane M; Chami L; Delbot T; Rouxel A; Leban M; Herve G; Menegaux F; Leenhardt L; Kas A; Trésallet C; Ghander C; Lussey-Lepoutre C
    World J Surg; 2019 May; 43(5):1232-1242. PubMed ID: 30659347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
    J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
    Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
    Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EANM practice guidelines for parathyroid imaging.
    Petranović Ovčariček P; Giovanella L; Carrió Gasset I; Hindié E; Huellner MW; Luster M; Piccardo A; Weber T; Talbot JN; Verburg FA
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2801-2822. PubMed ID: 33839893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
    Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
    Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
    Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
    Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas.
    Mazurek A; Dziuk M; Witkowska-Patena E; Chudzinski W; Piszczek S; Gizewska A; Saracyn M
    Endokrynol Pol; 2022; 73(1):43-48. PubMed ID: 35119087
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gass JM; Wicke C; Mona C; Strobel K; Müller W; Metzger J; Suter-Widmer I; Henzen C; Fischli S
    Endocrine; 2022 Feb; 75(2):593-600. PubMed ID: 34561784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Mandic A; Kraljevic I; Skoric Polovina T; Zibar Tomsic K; Dusek T; Balasko A; Solak M; Kastelan D
    Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls.
    Talbot JN; Zhang-Yin J; Kerrou K; Aveline C; Vagne B; Bélissant O; Tassart M; Périé S; Bouchard P; Christin-Maitre S; Ménégaux F; Groussin L; Gaujoux S; Balogová S; Montravers F
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):130-140. PubMed ID: 35005879
    [No Abstract]   [Full Text] [Related]  

  • 20. Head-to-head comparison of [
    Noltes ME; Kruijff S; Appelman APA; Jansen L; Zandee WT; Links TP; van Hemel BM; Schouw HM; Dierckx RAJO; Francken AB; Kelder W; van der Hoorn A; Brouwers AH
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1050-1059. PubMed ID: 37975887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.